Vertex Pharmaceuticals Inc / Ma
2014 Q2 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/28/2026 | 50,327 | 0.2% | 111,010 | 12/31/2025 |
| 2025 Q3 | 10/30/2025 | 46,467 | 0.2% | 118,648 | 9/30/2025 |
| 2025 Q2 | 8/1/2025 | 54,480 | 0.2% | 122,373 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 61,487 | 0.3% | 126,824 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 42,241 | 0.2% | 104,895 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 38,476 | 0.2% | 82,730 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 34,379 | 0.2% | 73,347 | 6/30/2024 |
| 2024 Q1 | 5/6/2024 | 30,060 | 0.2% | 71,913 | 3/31/2024 |
| 2023 Q4 | 2/7/2024 | 24,553 | 0.2% | 60,343 | 12/31/2023 |
| 2023 Q3 | 10/31/2023 | 23,706 | 0.2% | 68,171 | 9/30/2023 |
| 2023 Q2 | 7/19/2023 | 23,601 | 0.2% | 67,065 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 27,475 | 0.2% | 87,203 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 40,756 | 0.3% | 141,130 | 12/31/2022 |
| 2022 Q3 | 11/3/2022 | 42,306 | 0.3% | 146,114 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 39,518 | 0.3% | 140,240 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 42,420 | 0.2% | 162,546 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 24,762 | 0.1% | 112,760 | 12/31/2021 |
| 2021 Q3 | 11/9/2021 | 23,443 | 0.1% | 129,242 | 9/30/2021 |
| 2021 Q2 | 8/5/2021 | 38,788 | 0.2% | 192,373 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 37,734 | 0.2% | 175,598 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 60,703 | 0.4% | 256,848 | 12/31/2020 |
| 2020 Q3 | 11/2/2020 | 54,677 | 0.4% | 200,928 | 9/30/2020 |
| 2020 Q2 | 8/11/2020 | 42,597 | 0.3% | 146,728 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 21,313 | 0.2% | 89,568 | 3/31/2020 |
| 2019 Q4 | 2/6/2020 | 11,251 | 0.1% | 51,384 | 12/31/2019 |
| 2014 Q2 | 8/5/2014 | 41 | 0.0% | 431 | 6/30/2014 |